Future Scope of Antibiotic Resistance Biomarkers Industry
Future Scope of Antibiotic Resistance Biomarkers Industry
Antimicrobial resistance (AMR) occurs when microbes develop mechanisms that protect them from the effects of antimicrobial agents. The term antibiotic resistance is a subset of the AMR as it refers to bacteria that become resistant to antibiotics. Resistant microbes are more difficult to treat and require higher doses or alternative drugs, which can prove more toxic.Get Sample PDF
Some of the key players of Antibiotic Resistance Biomarkers Industry:
Thermo Fisher Scientific, Qiagen, Abbott, Bio-Rad Laboratories, Cube Dx GmbH, GenMark Diagnostic, Merck, Creative Diagnostic, Roche, HiMedia Laboratories, Danaher CorporatoryThese approaches can also be more expensive. Microbes that are resistant to multiple antimicrobial agents are known as multi-resistant (MDR). All classes of microbes can develop resistance. Fungi develop an antifungal resistance. Viruses develop antiviral resistance. Protozoa develop resistance to protozoa and bacteria develop resistance to antibiotics. Those bacteria that are considered largely drug resistant (XDR) or fully drug resistant (TDR) are sometimes referred to as "superbugs".
Resistance in bacteria can arise naturally, through genetic mutation, or when one species acquires resistance from another. Resistance can arise spontaneously due to random mutations. However, the expanded use of antimicrobial agents appears to encourage the selection of mutations that can render antimicrobial agents ineffective.
Comments
Post a Comment